Oral semaglutide and cardiovascular outcomes in persons with type 2 diabetes, according to SGLT2i use: prespecified analyses of the SOUL randomized trial
Marx N, Deanfield JE, Mann JFE, et al.
Circulation. Pub. online 29 Mar 2025.
Leggi
Marx N, Deanfield JE, Mann JFE, et al.
Circulation. Pub. online 29 Mar 2025.
Leggi
Wagh R, Hatem G, Andersson J, et al.
Diabetologia. Pub. online 2 Apr 2025.
Leggi
Billings LK, Winne L, Sharma P, et al.
Ann Intern Med. Pub. online 2 Apr 2025.
Leggi
Li JX, Hsu TJ, Lin HJ, et al.
JAMA Netw Open. 2025;8(3):e252577.
Leggi
McEvoy RP, Newman C, Egan AM, Dunne FP
Diabetes Obes Metab. Pub. online 2 Apr 2025.
Leggi
Hanif M, Hays AG, Nagarajan JS, et al.
Am J Cardiol. 2025;246:10-13.
Leggi
Koren MJ, Vega RB, Agrawal N, et al.
J Am Coll Cardiol. Pub. online 27 Mar 2025.
Leggi
Meek CL, Feig DS, Scott EM, et al.
Diabetes Care. 2025 Apr 2:dc242494.
Leggi
Lee MMY, Sattar N, Pop-Busui R, et al.
Diabetes Care. 2025:dc250241.
Leggi
Klonoff DC, Berard L, Franco DR, et al.
Mayo Clin Proc. Pub. online 1 Apr 2025.
Leggi